Literature DB >> 23047351

Off-label use of bone morphogenetic proteins in pediatric spinal arthrodesis.

Emily Dodwell1, Brian Snyder, James Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047351     DOI: 10.1001/jama.2012.12929

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Prevalence and Perioperative Outcomes of Off-Label Total Hip and Knee Arthroplasty in the United States, 2000-2010.

Authors:  Tennison Malcolm; Caleb R Szubski; Nicholas K Schiltz; Alison K Klika; Siran M Koroukian; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2015-05-19       Impact factor: 4.757

2.  Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics.

Authors:  Norbert Stiel; Tim N Hissnauer; Martin Rupprecht; Kornelia Babin; Carsten W Schlickewei; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  J Mater Sci Mater Med       Date:  2016-10-27       Impact factor: 3.896

3.  Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.

Authors:  Adam P Goode; William J Richardson; Robin M Schectman; Timothy S Carey
Journal:  Spine J       Date:  2013-12-07       Impact factor: 4.166

4.  Point-counter-point debate: the association between recombinant human bone morphogenetic protein utilization and complications in spine surgery.

Authors:  Kris Siemionow; Eric Sundberg; Marcin Tyrakowski; Sreeharsha V Nandyala; Kern Singh
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

5.  Dipyridamole-loaded 3D-printed bioceramic scaffolds stimulate pediatric bone regeneration in vivo without disruption of craniofacial growth through facial maturity.

Authors:  Maxime M Wang; Roberto L Flores; Lukasz Witek; Andrea Torroni; Amel Ibrahim; Zhong Wang; Hannah A Liss; Bruce N Cronstein; Christopher D Lopez; Samantha G Maliha; Paulo G Coelho
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.